B virus cytoplasmic tail sequences share common features that lead to the production of infectious virus. Transfectant virus was obtained with all cytoplasmic tail mutants generated by site-directed mutagenesis of the influenza A virus tail, except for the mutant resulting from substitution of the conserved proline residue, presumably because of its contribution to the secondary structure of the tail. No virus was rescued when the cytoplasmic tail was deleted, indicating that the cytoplasmic tail is essential for production of the virus. The virulence of the transfectant viruses in mice was directly proportional to the amount of NA incorporated. The importance of the NA cytoplasmic tail in virus assembly and virulence has implications for use in developing antiviral strategies.
The neuraminidase (NA) of influenza A virus is a type II membrane glycoprotein with an uncleaved amino-terminal signal/anchor domain and a cytoplasmic tail that is presumed to be intracellular (1) . The NA is thought to facilitate the mobility of virions by removing sialic acid residues from virus and infected cells during both entry and release from the cells (31) . The three-dimensional structure of the NA has been determined (9, 42) and indicates that the protein is a tetramer consisting of four identical disulfide-linked subunits. The ectodomain of NA consists of a stalk and a globular head (1) , with the latter containing the enzyme-active center and major antigenic sites. The hydrophobic transmembrane domain of NA serves as a signal sequence for membrane insertion and anchors the protein in the lipid bilayer (3) . The stalk and the transmembrane domain sequences are highly variable among the nine NA subtypes (10) . In contrast to the rest of the NA, however, the six-amino-acid cytoplasmic tail is highly conserved within the NA subtypes of influenza A virus. This extreme sequence conservation suggests that the sequence is critical to the function of this domain. However, the biological role of the NA cytoplasmic tail sequence has not been studied in detail.
The cytoplasmic tails of integral membrane proteins are of considerable interest because they may interact with cytoplasmic factors during protein synthesis, maturation, or intracellular transport. In the case of viral transmembrane glycoproteins, the cytoplasmic tails have the potential to interact with host and/or viral components and play a role in virus assembly. The cytoplasmic domains of viral surface glycoproteins may be structurally fixed against the cytoplasmic face of the membrane bilayer, providing potential binding sites for nucleocapsids and matrix proteins in initiating assembly. Direct interaction be-* Corresponding author. tween the nucleocapsid and a peptide corresponding to the cytoplasmic domain of the viral glycoprotein has been shown for Semliki Forest virus (26) . Similarly, a peptide corresponding to the cytoplasmic domain sequence of influenza virus hemagglutinin (HA) inhibits virus formation, suggesting virusspecific interactions between the HA and other viral proteins during viral assembly (7) . However, such interactions for NA have not yet been defined.
Reverse genetics systems to rescue cloned genes in negativestrand RNA viruses have recently been established (8, 23, 32, 36) . Palese and colleagues have rescued influenza A virus containing the chloramphenicol acetyltransferase gene (23) or influenza virus genes derived from cDNA (12) (13) (14) 28) . In the present study, we used the influenza virus reverse genetics system to analyze the functional significance of the highly conserved cytoplasmic tail sequence of influenza A virus NA. Reverse genetics. Construction of pT3WSN(NA15), a plasmid containing the WSN NA gene flanked by an upstream T3 RNA polymerase promoter sequence and a downstream Ksp6321 site, has been described previously (5) . Cytoplasmic tail mutants were constructed from pT3WSN(NA15) by oligonucleotide-directed mutagenesis (20) . An in vitro ribonucleo- (15) . Briefly, HeLa T4 cells were infected with vaccinia virus expressing T7 RNA polymerase (vTF7-3), and then the Bluescript NA plasmids were transfected by lipofectin (Bethesda Research Laboratories) as described by Nuss and Air (30) .
MATERIALS AND METHODS

Viruses
The cells were fixed with 3.7% formaldehyde at various time points and subjected to indirect immunofluorescence as described earlier (43) with a monoclonal antibody to WSN NA. The transfected cells were also assayed for enzyme activity by preparing cell lysates with lysis buffer and performing standard NA assays with fetuin as the substrate (2) .
RESULTS
Rescue of NA cytoplasmic tail mutants. To understand the significance of the sequence conservation of the cytoplasmic tail of the influenza A virus NA, we conducted a mutational analysis of the cytoplasmic tail of A/WSN/33 NA. Our strategy was to mutate the influenza A virus NA cytoplasmic tail sequence to that of influenza B virus NA (38) . The sevenamino-acid influenza B virus NA tail sequence differs from that of influenza A virus NA at all positions except for the initiating methionine and third-position proline (Fig. 1 ). Our rationale for choosing the influenza B virus NA sequence was to use a closely related virus which may share common structural features so as not to severely impair cytoplasmic tail function. The mutations included single-amino-acid substitutions, deletions, and insertions and substitution of influenza A virus NA tail with influenza B virus NA. The results obtained with each mutant are discussed individually below.
FLUBCYT. The WSN NA cytoplasmic tail was replaced by the influenza B virus NA cytoplasmic tail (Table 1) . This chimeric NA rescued influenza A virus infectivity, indicating that the influenza B virus NA sequence can substitute for the conserved influenza A virus NA sequence in the production of virus. However, the FLUBCYT transfectant virus produced smaller plaques than wild-type WSN (diameter, 0.5 versus 1.3 mm) yet grew to titers comparable to those with WSN (Table  2 ). These results suggest that the influenza A and influenza B virus NA cytoplasmic tails share common structural features that lead to the production of infectious virus.
CYT 2B, 4B, 5B, and 6B. To systematically assess the significance of the conservation of influenza A virus NA residues, each amino acid in the WSN cytoplasmic tail sequence was individually changed to that of the influenza B virus NA sequence. The name of each mutant indicates the position that contains the corresponding influenza B virus NA residue ( Table 1 ). All of these single-amino-acid mutants rescued influenza A virus infectivity. The transfectant viruses produced plaques in MDBK cells similar in morphology and size to those of WSN (diameter, 1.3 mm) and grew to titers equivalent to that of wild-type WSN (Table 2) .
CYT 7B. The seventh residue (Gln) of the influenza B virus NA tail was inserted between the influenza A virus NA tail and (Table 2) .
Virulence in mice. The differences in growth characteristics and plaque sizes observed in tissue cultures for the transfectant viruses suggested that the mutations in the cytoplasmic tail of the NA may alter virus infectivity in vivo. Therefore, all of the transfectant viruses were tested for virulence in mice. WSN transfectant virus was highly virulent in mice (Table 3) . CYT 2B, 4B, and SB were virulent, but only CYT 6B was as virulent as WSN. In contrast, CYT 7B and FLUBCYT were highly attenuated. CYT 7B did not kill any mice; therefore, no endpoint MLD50 titer was determined.
Cell surface expression of NA cytoplasmic tail mutants. Transfectant virus was not obtained with NO PRO and NO TAIL NAs. To determine whether these NAs as well as the NAs from the attenuated viruses were transport defective or functionally aberrant relative to WSN, the mutant NAs were transiently expressed by the T7-vaccinia virus system and analyzed for cell surface expression.
Mutant NA genes under the control of the bacteriophage T7 RNA polymerase promoter were transfected into HeLa T4 cells that were infected with a recombinant vaccinia virus expressing the T7 RNA polymerase (vTF7-3). The cells were fixed and examined for NA surface expression by indirect immunofluorescence at various time intervals (3, 6, 9, 12, 15, and 18 h posttransfection). All of the mutant NA proteins were expressed at the cell surface and at levels comparable to those with WSN in reproducible experiments. The rates of appearance of the mutant NAs at the cell surface were similar to that of WSN NA (Table 4 ). The expression of NO PRO and NO TAIL NAs at the cell surface indicates that the reason for their rescue deficiency was not because of a lack of surface expression. (Fig. 2B) .
WSN NA was efficiently incorporated into virions ( Fig. 2A) . CYT 2B, 4B, SB, and 6B had levels of incorporated NA that were similar to that of WSN (Fig. 2A) , whereas FLUBCYT and CYT 7B had significantly reduced amounts of incorporated NA (Fig. 2A) . Similar results were observed with MDCK cells. The similar ratios of HA to NA in cell lysates (Fig. 2B) suggest that the drastic ratio differences observed in virions are due not to reduced levels of NA expression but to incorporation efficiency. These results suggest that the virulence of FLUBCYT and CYT 7B in mice is attenuated because of poor incorporation of NA into the virion.
NA activities of transfectant viruses. Standard NA assays were performed in order to correlate the amounts of incorporated NA with the enzymatic activity for each of the purified transfectant viruses. Identical amounts of purified virus based on protein concentrations were incubated with fetuin, and NA activities were compared at various time points. Figure 3A is representative of replicate assays depicting the NA activities of WSN and the mutants over a 24-h time course. The NA activities of CYT 4B, SB, and 6B were similar to that of WSN throughout the duration of the reaction. CYT 2B displayed the same level of activity as WSN by 24 h, despite a lag in the early stages of the reaction (Fig. 3B) CYT 7B did not deplete the substrate by 24 h, as had all of the other viruses, suggesting different enzymatic rates. Therefore, the NA activities were measured at earlier time points to compare the initial rates (Fig. 3B) . FLUBCYT and CYT 7B showed significantly less NA activity than WSN. The decrease in NA activity observed for CYT 7B and FLUBCYT in the initial stages of the reaction correlates with the reduction in the incorporation of NA into virions.
DISCUSSION
To understand the role of the conserved residues in the cytoplasmic tail, cytoplasmic tail mutants of NA were used to rescue influenza A virus infectivity. Our (40) . However, the mutations may also alter the structure of the cytoplasmic tail and have adverse effects on incorporation into virus. The configuration of the cytoplasmic tail in the NA tetramer is not known; presumably, however, it must be able to interact with other viral proteins and/or nonviral factors during the assembly process. The significance of the constraints on the cytoplasmic tail structure can be seen by altering the proline that is conserved between influenza A virus tail and influenza B virus tail. The NA containing an alanine instead of proline (NO PRO) did not rescue infectious virus. However, the transiently expressed NO PRO NA was transported to the cell surface and was enzymatically functional. The proline residue may maintain the cytoplasmic tail in a proper conformation along the membrane to interact with the components of the budding virion. A/New Jersey/8/76 (27) and Ni swine isolates (18a) contain a threonine instead of the proline accompanied by a lysine-to-arginine change in the sixth residue of the cytoplasmic tail. The effect of those residues on the rescue of WSN NA has not yet been determined.
All of the NA cytoplasmic tail mutants, including NO TAIL and NO PRO, were expressed at the cell surface with rates of appearance similar to that of WSN in a transient vaccinia virus expression system. These results indicate that the signals for intracellular transport of NA are not contained within the cytoplasmic tail, in agreement with previous studies that mapped the translocation signals and membrane anchor to the hydrophobic transmembrane domain (3, 40) . The oligomeric state of the NA cytoplasmic tail mutants was not directly addressed; however, the transiently expressed mutant NAs were functional, indicating that they had attained the proper oligomeric structure. Only tetrameric forms of NA are thought to be enzymatically active (10, 19, 34) .
The requirement for cytoplasmic tails in viral surface glycoproteins varies. Deletion of the cytoplasmic tail of the Rous sarcoma virus envelope glycoprotein has no effect on assembly or virus infectivity (37) . However, the cytoplasmic domain of the human immunodeficiency virus type I envelope glycoprotein appears to play a role in viral entry (16) , which may in part be due to inefficient incorporation of the glycoprotein into virus (11) . In other enveloped viruses, the cytoplasmic domain of the vesicular stomatitis virus glycoprotein (G) is required for incorporation of G protein into viral particles (44) . In contrast, the tailless mutant of influenza virus HA is incorporated into virions but is blocked in infectivity (39) . Our NO TAIL NA was transported to the cell surface, but no transfectant virus was obtained. This suggests that the cytoplasmic tail may be essential for the incorporation of NA into virus. Alternatively, the tail may be expendable for incorporation into virions but may be required subsequently for the virus to initiate a new round of infection.
Recent data with Sindbis virus E2 glycoprotein revealed that the E2 tail is important for virus budding (17) . Specific interactions between viral glycoproteins and components of the budding virus have been suggested for alphaviruses (26) , Mason-Pfizer monkey virus (4), Rous sarcoma virus (18) and vesicular stomatitis virus (24) . The influenza virus matrix protein MI is presumed to mediate the interaction between glycoproteins and nucleocapsids during virus assembly (25) , and it has been suggested that specific signals required for influenza virus assembly may be contained in M, NP, or NA (35, 39) . A recent study has suggested that the cytoplasmic domains of the envelope proteins may serve in binding to other viral components in order to avoid being excluded from the envelope during assembly (29) . Synthetic peptides matching the cytoplasmic domains of Sindbis virus E2, vesicular stomatitis virus G, and influenza virus HA have virus-specific antiviral activities in infected tissue culture cells (6, 7) . The data presented here suggest that peptides corresponding to the NA cytoplasmic tail may also be a target in the design of antiviral compounds.
